Awilda Rodriguez
Nurse Practitioner · Bryn Mawr, PANPI 1043802648
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 408 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $6,933, more than ten times the $473 reported in 2021. Among nurse practitioner clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 408 payments — averaging $24.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$729
- Axsome Therapeutics, Inc.$687
- Jazz Pharmaceuticals Inc.$657
- Mallinckrodt Hospital Products Inc.$513
- Harmony Biosciences LLC$469
- plus $5K from 36 others
What the payments were for
- Food & beverage$9,68798%
- Education$2102%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,897 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 59 | $50,020 |
| KerendiaFinerenone | 19 | $12,939 |
| LokelmaSodium Zirconium Cyclosilicate | 11 | $7,619 |
| JanuviaSitagliptin Phosphate | 12 | $6,147 |
| Potassium Citrate ErPotassium Citrate | 34 | $4,260 |
| Valsartan | 41 | $1,518 |
| Amlodipine Besylate | 212 | $1,368 |
| Chlorthalidone | 54 | $1,350 |
| Metoprolol Succinate | 81 | $1,197 |
| Losartan Potassium | 74 | $883 |
| Hydralazine Hcl | 39 | $856 |
| Torsemide | 30 | $838 |
| Bumetanide | 16 | $792 |
| Allopurinol | 56 | $735 |
| Olmesartan Medoxomil | 33 | $693 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Lokelma | $2,295 | $57,63970 claims |
| BayerKerendia | $405 | $12,93919 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $85 | $1,51841 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Bryn Mawr
- Susan SpadtBryn Mawr$26K
- Gina PagottoBryn Mawr$11K
- Kristina BonesteelBryn Mawr$9K
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.